EDAP TMS S.A. (FOCL:NASDAQ) closed at $3.25 on November 13, 2026, down 4.84% on the day. The stock trades 49.3% below its 52-week high of $6.40 and 66.4% above its 52-week low of $1.95. Over the past year, it gained 39.3%. EDAP TMS S.A. is part of the Health Care sector.
In 235 trading sessions since December 9, 2025, FOCL closed higher on 111 days (47%). Its best day was December 12, 2025 (+22.55%) and its worst was November 6, 2026 (-21.88%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 1 time.
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer.
Find more stocks like FOCL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.